The authors' results revealed that this combination contributes to reducing tumor growth by upregulating the apoptosis-associated proteins (BAX and PUMA), the tumor suppressors (P53, P57), and the BAX:BCL-2 ratio (Rahman et al., 2024[178]). The gene discussed is BCL2; the disease is neoplasm.